Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 458 clinical trials
TRIple Negative Breast Cancer Markers In Liquid Biopsies Using Artificial Intelligence

Triple negative breast cancer (TNBC) is the most aggressive of breast cancers and it is usually treated with chemotherapy even before surgery. In many cases, the chemotherapy completely "melts

  • 3 views
  • 14 May, 2021
  • 4 locations
Evaluation of a Plasma Protein Profile as a Predictive Biomarker for Metastatic Relapse in Triple Negative Breast Cancer Patients (INSTIGO)

The INSTIGO study aims to assess a plasma protein profile at different stages of patient follow-up as a predictive factor of metastatic recurrence in triple negative breast cancer. It also aims

triple negative breast cancer
  • 0 views
  • 23 Mar, 2022
  • 1 location
CTC Changes and Efficacy of Neoadjuvant Chemotherapy for Triple-negative Breast Cancer

chemotherapeutic drugs and create opportunities for breast-conserving or surgical treatment for patients. This may lead to high survival opportunities for triple-negative breast cancer patients who are not

mammogram
paclitaxel
breast cancer
anthracyclines
stage iii breast cancer
  • 1 views
  • 25 Mar, 2022
  • 2 locations
Treatment Decision Making in African American Women Diagnosed With Triple Negative Breast Cancer

This study evaluates what influences treatment decision-making in African American women with triple negative breast cancer. The study also aims to learn about the influence of information

  • 0 views
  • 21 Mar, 2022
  • 1 location
De-convoluting Interactions Between Genes, the Cancer Environment, and the Immune System to Develop Therapies That Work for You (DIGNITY)

This is a live biobank study for Triple negative breast cancer (TNBC) patients where samples will be collected at inflection points in the course of the disease.

triple negative breast cancer
metastasis
  • 0 views
  • 24 Apr, 2022
  • 2 locations
Predictors of Response to Neoadjuvant Docetaxel-Carboplatin Chemotherapy for Patients With Stage II and III Triple Negative Breast Cancer

performed using FFEP tissue. Triple Negative Breast Cancer (TNBC) is defined by a lack of expression of ER, PgR and HER-2. DNA microarray profiling studies have led to the classification of invasive

breast cancer staging
anthracyclines
BRCA1
invasive breast cancer
breast carcinoma
  • 0 views
  • 04 Sep, 2021
  • 1 location
Brain Monitoring for High Risk of Brain Metastases in Metastatic Breast Cancer

Imaging) can detect early brain metastases and influence survival through early brain management in HER2-positive and triple negative breast cancer.

brain metastases
breast cancer
metastasis
cancer
HER2
  • 0 views
  • 26 Jan, 2021
  • 1 location
Comparison of the Breast Tumor Microenvironment

receiving intraoperative radiation therapy (IORT) in subjects that have luminal A and triple negative breast cancer. IORT is considered as being standard of care.

mammogram
growth factor
breast carcinoma
lobular carcinoma
breast-conserving surgery
  • 1 views
  • 02 Sep, 2021
  • 1 location
Multiparametric MRI as a Non-Invasive Biomarker of the Tumor Microenviroment

This study is looking at how an imaging test could help doctors understand if a patient with early breast cancer will respond to drugs that use the patient's immune system to fight cancer.

growth factor
estrogen
epidermal growth factor
invasive breast cancer
metastasis
  • 0 views
  • 19 Apr, 2022
  • 1 location
CT-based Radiomics of ALN pCR (ypN0) in Breast Cancer Undergoing NAC

This is a prospective, single-center, non-randomized, non-controlled observational study.

HER2
metastasis
erbb2
core needle biopsy
invasive breast cancer
  • 0 views
  • 01 May, 2022
  • 1 location